- Home
- LFCR vs HRTX Comparison
LFCR vs HRTX Comparison
Compare LFCR & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.36
HOLD
Current Price
$1.20
Company Overview
Basic Information| Metric | LFCR | HRTX |
|---|---|---|
| Founded | 1986 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.8M | 265.9M |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | LFCR | HRTX |
|---|---|---|
| Price | $7.36 | $1.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 123.7K | ★ 1.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.75 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $557,559,000.00 | $144,285,000.00 |
| Revenue This Year | $2.80 | $8.78 |
| Revenue Next Year | $11.51 | $11.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 6.36 | ★ 13.57 |
| 52 Week Low | $4.76 | $1.00 |
| 52 Week High | $8.98 | $2.68 |
Technical Indicators
Market Signals| Indicator | LFCR | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 45.34 |
| Support Level | $7.30 | $1.07 |
| Resistance Level | $8.57 | $1.34 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 38.95 | 50.00 |
Price Performance
Historical Comparison LFCR
HRTX
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.